Status:
COMPLETED
Comparative Retrospective Analysis of Skin Tumors of the Eyelids and Face in 2 Brussels University Hospitals Over 5 Years in Dermatology or Ophthalmology
Lead Sponsor:
Brugmann University Hospital
Conditions:
Skin Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Skin cancers are the most common of all cancers. Their incidence has increased sharply over the decades.This increase in incidence partly reflects an aging population and behavioral patterns such as r...
Eligibility Criteria
Inclusion
- Final diagnosis confirmed by pathological analysis, epidemiological and clinical information available from patients.
Exclusion
- Patients who have expressed a refusal to access their medical file or incomplete data will not be taken into account.
Key Trial Info
Start Date :
February 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 28 2021
Estimated Enrollment :
373 Patients enrolled
Trial Details
Trial ID
NCT04886908
Start Date
February 9 2021
End Date
July 28 2021
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020